These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 18076440

  • 1. Comorbidity in nasopharyngeal carcinoma: a preliminary communication on the prevalence, descriptive distribution and impact on outcome.
    Ramakrishnan Y, Paleri V, Shah R, Steen IN, Wight RG, Kelly CG.
    Clin Otolaryngol; 2007 Dec; 32(6):484-8. PubMed ID: 18076440
    [Abstract] [Full Text] [Related]

  • 2. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC, Piccirillo JF.
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [Abstract] [Full Text] [Related]

  • 3. Importance of comorbidity in head and neck cancer.
    Piccirillo JF.
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [Abstract] [Full Text] [Related]

  • 4. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
    Guo ZM, Liu WW, He JH.
    Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
    [Abstract] [Full Text] [Related]

  • 5. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
    Lee CC, Chu ST, Chou P, Lee CC, Chen LF.
    Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Descriptive study of the type and severity of decompensation caused by comorbidity in a population of patients with laryngeal squamous cancer.
    Paleri V, Narayan R, Wight RG.
    J Laryngol Otol; 2004 Jul; 118(7):517-21. PubMed ID: 15318957
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
    Gourin CG, Boyce BJ, Vaught CC, Burkhead LM, Podolsky RH.
    Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Importance of comorbidity in hypopharyngeal cancer.
    Homma A, Sakashita T, Oridate N, Suzuki F, Suzuki S, Hatakeyama H, Mizumachi T, Taki S, Fukuda S.
    Head Neck; 2010 Feb; 32(2):148-53. PubMed ID: 19536763
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Nasopharyngeal carcinoma: epidemiology and treatment outcome].
    Balm AJ, Plaat BE, Hart AA, Hilgers FJ, Keus RB.
    Ned Tijdschr Geneeskd; 1997 Nov 29; 141(48):2346-50. PubMed ID: 9550826
    [Abstract] [Full Text] [Related]

  • 17. Deprivation, comorbidity and survival in a cohort of patients with colorectal cancer.
    Munro AJ, Bentley AH.
    Eur J Cancer Care (Engl); 2004 Jul 29; 13(3):254-62. PubMed ID: 15196229
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.